NeoStem’s overnight offering investors partially exercised … the over-allotment option granted to the underwriters to purchase an additional 1.5 M shares of its common stock, at a price to the public of $0.50 per share, in connection with NBS’ recently announced underwritten public offering of 20 M shares of common stock, bringing total gross proceeds from the offering to $10.75 M before deducting underwriting discounts and commissions and other offering expenses payable.
The Bottom Line: The deal is done with the additional caveat of the over-allotment being picked off! Big point – NO WARRANTS! Fortunately, for those who truly understand the magnitude and potential of this company it’s a good price … that must and will be followed by supporting news and factual commentary to sustain the pricing.
NBS closed at $0.50 down -20.63 but is UP in the aftermarket +$0.01 or +2% to $0.51 – a healthy sign <post event> of more to come.